Zhongyuan Union Cell & Gene Eng

Zhongyuan Union Cell & Gene Eng is a company listed under the stock ticker 600645 (CN).

View the org chart displaying its 6 main executives

Most searched biographies at Zhongyuan Union Cell & Gene Eng

• Yong Wang, Chairman of the Board and General Manager
• Xueliang Sun, Director
• Renzhong Yan, Independent Director

Create your alert
to follow the executive moves at Zhongyuan Union Cell & Gene Eng.

Zhongyuan Union Cell & Gene Eng has 2,282 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Zhongyuan Union Cell & Gene Eng

• Research | VcanBio Center for Translational Biotechnology

Social media about Zhongyuan Union Cell & Gene Eng

• Zhongyuan Union Cell & Gene Eng on Wikipedia, Google News & Yahoo Finance
• Zhongyuan Union Cell & Gene Eng on LinkedIn, Twitter & YouTube

Call Zhongyuan Union Cell & Gene Eng at +86 225...

View the org chart

Register to receive your alert

Report an error